GO:0010716 negative regulation of extracellular matrix disassembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010716 describes any process that decreases the rate, frequency or extent of extracellular matrix disassembly, the breakdown of the extracellular matrix (ECM).
• ECM disassembly is executed by secreted and membrane-bound proteases, and its negative regulation occurs at the level of protease gene expression, protease activation, and physical protection of matrix substrates.
• Chromatin remodeling and transcription factor cooperation control expression of ECM components and ECM-remodeling genes, providing a nuclear entry point for negative regulation of ECM disassembly.
• Adhesion structures such as focal adhesions and podosomes are mechanistically coupled to ECM turnover, and their disassembly or stabilization directly modulates ECM degradation.
• Dysregulated ECM disassembly underlies cancer invasion, fibrosis, arthritis, and developmental defects, making GO:0010716 a high-value target for mechanistic and therapeutic studies.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate negative regulators of ECM disassembly in relevant cell types.
Description
The extracellular matrix (ECM) is a dynamic network of collagens, proteoglycans, glycoproteins, and associated factors that provides structural support and biochemical signals to cells. Its controlled breakdown, termed extracellular matrix disassembly, is essential for tissue remodeling, cell migration, and development. GO:0010716, negative regulation of extracellular matrix disassembly, refers to any process that decreases the rate, frequency or extent of this breakdown. Because excessive or mislocalized ECM degradation drives tumor invasion, chronic inflammation, and fibrotic remodeling, understanding the mechanisms that restrain ECM disassembly is of broad biomedical importance. Mechanistically, negative regulation of ECM disassembly can be achieved by limiting the expression or activity of ECM-degrading proteases, by increasing the deposition or cross-linking of matrix components, or by altering the physical and signaling context in which cells contact the matrix. Chromatin-level control of ECM gene expression has emerged as a central node: SWI/SNF chromatin-remodeling complexes cooperate with transcription factors to regulate ECM-responsive gene expression, and endothelial chromatin-remodeling enzymes control production of critical ECM components during lung development. Infection and inflammatory states can also reshape chromatin accessibility and ECM-related transcriptional programs. At the cellular level, adhesion structures physically couple cells to the ECM and influence whether matrix is preserved or degraded. Focal adhesion kinase (FAK) controls motile and invasive cell phenotypes that depend on ECM remodeling, while adhesion-derived condensates regulate the availability of adhesion components and thereby adhesion dynamics. Osteoclast podosomes, which are actin-rich adhesion structures specialized for matrix degradation, undergo disassembly in response to osteoprotegerin through calcium, ERK, and p38 MAPK signaling, illustrating how negative regulation of matrix breakdown can be achieved by dismantling the degradation machinery itself. Together, these studies define GO:0010716 as an integrative process spanning transcription, adhesion biology, and protease control.
negative regulation of extracellular matrix disassembly At A Glance
| GO ID | GO:0010716 |
|---|---|
| GO term | negative regulation of extracellular matrix disassembly |
| Ontology | biological_process |
| Definition | Any process that decreases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix. |
| Synonyms | down regulation of extracellular matrix disassembly; down-regulation of extracellular matrix disassembly; downregulation of extracellular matrix disassembly; inhibition of extracellular matrix disassembly; negative regulation of extracellular matrix breakdown; negative regulation of extracellular matrix degradation |
| Major function | Restraining protease-driven breakdown of ECM components to preserve matrix integrity and tissue architecture |
| Regulatory level | Transcriptional and chromatin-level control of ECM and ECM-remodeling genes; post-translational control of protease activity; adhesion-structure dynamics |
| Key cellular contexts | Fibroblasts, endothelial cells, epithelial cells, osteoclasts, invasive cancer cells |
| Disease relevance | Cancer invasion and metastasis, fibrosis, inflammatory bone disease, developmental ECM defects |
What Is GO:0010716?
GO:0010716 (negative regulation of extracellular matrix disassembly) is a biological process term describing any process that decreases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is the process that results in breakdown of the extracellular matrix. In practice, this term covers mechanisms that suppress protease-mediated matrix degradation, including transcriptional repression of matrix-degrading enzymes, enhanced deposition or stabilization of matrix components, and disassembly or inactivation of cellular structures dedicated to matrix degradation.
Why Is negative regulation of extracellular matrix disassembly Important in Cell Biology?
Negative regulation of extracellular matrix disassembly is important because the balance between ECM synthesis and ECM breakdown determines tissue architecture, mechanical properties, and signaling competence. When this negative regulation fails, unrestrained ECM degradation promotes tumor cell invasion and metastasis, while excessive matrix preservation contributes to fibrosis and stiffening. Chromatin-remodeling complexes and transcription factors that control ECM gene expression provide a nuclear layer of negative regulation, and endothelial chromatin-remodeling enzymes are required for production of critical ECM components during lung development. Adhesion structures such as focal adhesions and podosomes are the physical platforms where matrix degradation occurs, and their regulated disassembly or stabilization directly tunes ECM turnover. Consequently, GO:0010716 sits at the intersection of cancer biology, developmental biology, immunology, and matrix medicine.
• Controls the balance between ECM deposition and degradation, which determines tissue stiffness and architecture.
• Restrains invasive cell phenotypes driven by focal adhesion kinase signaling.
• Regulates podosome disassembly in osteoclasts, linking matrix preservation to bone biology.
• Is influenced by chromatin accessibility and SWI/SNF-dependent transcription of ECM genes.
• Modulates epithelial-to-mesenchymal transition induced by ECM density and weakened cell-cell adhesion.
• Provides mechanistic entry points for anti-invasive and anti-fibrotic therapeutic strategies.
• Couples adhesion-derived condensates and adhesion dynamics to matrix turnover.
• Is relevant to developmental processes such as murine lung ECM maturation.
• Can be studied with CRISPR knockout, point mutation, knock-in, and overexpression models.
• Serves as a systems-level node integrating transcription, adhesion, and protease biology.
What Happens During negative regulation of extracellular matrix disassembly?
Transcriptional and chromatin-level suppression of ECM-degrading programs
In simple terms: The cell can turn down the genes that chew up the matrix.
Negative regulation of ECM disassembly begins when cells reduce expression of genes encoding matrix-degrading proteases and their activators. ECM-regulated gene expression requires cooperation of SWI/SNF chromatin-remodeling complexes and transcription factors, meaning that the accessibility of ECM-responsive promoters is a determinant of whether matrix-remodeling genes are expressed. Chromatin accessibility dynamics in infected epithelial cells further show that ECM-related transcriptional programs are remodeled in response to environmental cues. Endothelial chromatin-remodeling enzymes regulate production of critical ECM components during murine lung development, demonstrating that chromatin state controls the matrix side of the balance as well.
Control of adhesion structures that execute matrix degradation
In simple terms: Cells use sticky feet to degrade matrix, and taking those feet apart stops degradation.
Focal adhesions and podosomes are actin-rich adhesion structures that physically couple cells to the ECM and concentrate proteolytic activity at the cell-matrix interface. Focal adhesion kinase (FAK) controls motile and invasive cell phenotypes that depend on ECM remodeling, so modulation of FAK signaling restrains invasive behavior. Adhesion-derived condensates control the availability of adhesion components and thereby regulate adhesion dynamics, providing a biophysical mechanism by which adhesion assembly state is tuned. In osteoclasts, osteoprotegerin induces podosome disassembly through calcium, ERK, and p38 MAPK signaling pathways, directly demonstrating that dismantling the degradation machinery is a route to negative regulation of ECM disassembly.
Matrix density and cell-cell adhesion feedback
In simple terms: A denser matrix can change how cells stick to each other and to the matrix.
ECM density promotes epithelial-to-mesenchymal transition by weakening cell-cell adhesions, illustrating that matrix physical properties feed back on cell adhesion states that in turn influence matrix remodeling. This feedback means that negative regulation of ECM disassembly is not only a cell-intrinsic decision but also a consequence of the mechanical and biochemical state of the matrix itself. Changes in matrix density can therefore shift cells between matrix-preserving and matrix-degrading phenotypes.
Receptor-mediated modulation of matrix recognition
In simple terms: Receptors that recognize matrix can change cell shape and behavior.
Macrophage MARCO receptor expression induces formation of dendritic plasma membrane processes, showing that matrix-recognizing receptors can drive dramatic remodeling of the cell surface and adhesion context. Such receptor-driven changes in membrane architecture alter how cells interact with ECM and can indirectly influence whether matrix is preserved or degraded. This places scavenger and matrix-recognition receptors within the broader regulatory network of GO:0010716.
Integration of signaling pathways that restrain degradation
In simple terms: Several signaling pathways act together to keep matrix breakdown in check.
Calcium, ERK, and p38 MAPK signaling converge to induce podosome disassembly in osteoclasts, providing a concrete example of signal integration in negative regulation of ECM disassembly. FAK signaling controls invasive phenotypes that require ECM degradation, so its modulation represents another signaling axis that restrains matrix breakdown. Chromatin-remodeling enzymes and transcription factors add a slower, transcriptional layer that sets the ceiling on how much degradation machinery a cell can produce. Together, these fast and slow layers determine the net rate of ECM disassembly.
Key Genes Involved in GO:0010716 negative regulation of extracellular matrix disassembly
The following genes and proteins have been experimentally linked to negative regulation of extracellular matrix disassembly or to the ECM-remodeling processes it controls.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTK2 (FAK) | Controls motile and invasive cell phenotypes dependent on ECM remodeling | Modulation of FAK signaling restrains invasive behavior and ECM degradation |
| SMARCA4 (BRG1) | SWI/SNF chromatin-remodeling ATPase cooperating with transcription factors for ECM-regulated gene expression | Chromatin-level control of ECM-responsive transcription |
| SMARCB1 (SNF5) | Core SWI/SNF subunit required for ECM-regulated gene expression | Component of the SWI/SNF complex that cooperates with transcription factors |
| TNFRSF11B (OPG) | Induces podosome disassembly in osteoclasts via calcium, ERK, and p38 MAPK | Direct negative regulator of the matrix-degradation machinery |
| MARCO | Macrophage scavenger receptor that induces dendritic plasma membrane processes | Receptor-driven changes in adhesion and membrane architecture |
| Chromatin-remodeling enzymes (endothelial) | Regulate production of critical ECM components during murine lung development | Links chromatin state to ECM composition |
| ECM component genes | Encode collagens, proteoglycans, and glycoproteins that constitute the matrix | Their expression determines substrate availability for disassembly |
| Matrix-degrading proteases | Execute ECM disassembly and are targets of negative regulation | Transcriptional and post-translational suppression reduces matrix breakdown |
| Adhesion complex components | Form focal adhesions and podosomes that concentrate proteolysis | Their assembly state tunes ECM degradation |
| Adhesion-derived condensate proteins | Control availability of adhesion components | Biophysical regulation of adhesion dynamics |
| Calcium signaling effectors | Mediate osteoprotegerin-induced podosome disassembly | Signal integration in negative regulation of ECM disassembly |
| ERK MAPK pathway components | Transmit signals that induce podosome disassembly | Kinase pathway controlling degradation machinery |
| p38 MAPK pathway components | Transmit stress signals that induce podosome disassembly | Kinase pathway controlling degradation machinery |
| Epithelial adhesion molecules | Maintain cell-cell adhesions weakened by high ECM density | Link matrix density to EMT and remodeling |
| Transcription factors cooperating with SWI/SNF | Drive ECM-regulated gene expression | Nuclear effectors of ECM-responsive transcription |
| Chlamydia-responsive chromatin regulators | Alter chromatin accessibility in infected epithelial cells | Infection-linked remodeling of ECM transcriptional programs |
How Is negative regulation of extracellular matrix disassembly Regulated?
Negative regulation of extracellular matrix disassembly is controlled at multiple levels. At the chromatin level, SWI/SNF complexes cooperate with transcription factors to enable ECM-regulated gene expression, so the accessibility of ECM-responsive regulatory elements sets the transcriptional ceiling for matrix-remodeling genes. Chromatin accessibility is dynamically remodeled in infected epithelial cells, showing that environmental and infectious cues can reprogram these programs. Endothelial chromatin-remodeling enzymes are required for production of critical ECM components during murine lung development, linking chromatin state to the matrix side of the balance. At the signaling level, calcium, ERK, and p38 MAPK pathways converge to induce podosome disassembly in osteoclasts, providing a rapid post-translational route to restrain matrix degradation. FAK signaling controls invasive phenotypes that depend on ECM remodeling, so its modulation represents an additional regulatory input. Finally, adhesion-derived condensates regulate the availability of adhesion components and thereby adhesion dynamics, adding a biophysical layer of control.
negative regulation of extracellular matrix disassembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTK2 (FAK) | Cancer invasion and metastasis | Knockout and point-mutation models in invasive cancer cell lines |
| TNFRSF11B (OPG) | Inflammatory bone loss and osteoclast biology | Knockout and overexpression models in osteoclast differentiation cultures |
| SMARCA4 (BRG1) | ECM gene expression and developmental matrix defects | Knockout and knock-in models in endothelial and epithelial cells |
| MARCO | Macrophage matrix recognition and membrane remodeling | Overexpression and knockout models in macrophage lines |
| Chromatin-remodeling enzymes | Pulmonary ECM development and infection-linked remodeling | Knockout models in lung endothelial cells and infected epithelial cells |
Cancer invasion and metastasis
Loss of negative regulation of ECM disassembly permits tumor cells to degrade basement membrane and interstitial matrix, a prerequisite for invasion and metastasis. FAK controls motile and invasive cell phenotypes that depend on ECM remodeling, and its dysregulation is associated with invasive cancer behavior. High ECM density promotes epithelial-to-mesenchymal transition by weakening cell-cell adhesions, further favoring a migratory and matrix-degrading phenotype. Restoring negative regulation of ECM disassembly is therefore a rational anti-invasive strategy.
Bone and inflammatory disease
Osteoclasts degrade bone matrix through podosomes, and osteoprotegerin induces podosome disassembly via calcium, ERK, and p38 MAPK signaling. This places negative regulation of ECM disassembly at the center of bone remodeling and inflammatory bone loss. Therapeutic modulation of podosome disassembly pathways could restrain pathological bone resorption.
Developmental and pulmonary ECM disorders
Endothelial chromatin-remodeling enzymes regulate production of critical ECM components during murine lung development, indicating that perturbation of these regulators can produce developmental ECM defects. Because ECM composition determines substrate availability for disassembly, defects in matrix production indirectly alter the effective level of negative regulation of ECM disassembly. Chromatin accessibility changes in infected epithelial cells further suggest that infection can reprogram ECM-related programs in barrier tissues.
Fibrosis and matrix stiffening
When negative regulation of ECM disassembly is excessive relative to deposition, matrix accumulates and tissue stiffens. ECM density itself promotes epithelial-to-mesenchymal transition by weakening cell-cell adhesions, creating a feed-forward loop between matrix accumulation and cellular phenotype. Chromatin-level control of ECM gene expression provides a potential intervention point to rebalance matrix turnover in fibrotic disease.
From negative regulation of extracellular matrix disassembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for negative regulation of ECM disassembly? | CRISPR knockout in a matrix-degrading cell type |
| Does a specific phosphorylation site control podosome disassembly? | CRISPR point mutation at the phospho-acceptor residue |
| Does a disease-associated variant alter ECM preservation? | CRISPR knock-in of the variant allele |
| Where does a candidate regulator localize during matrix turnover? | Endogenous tagged knock-in |
| Does increased dosage of a regulator suppress ECM degradation? | CRISPR overexpression (safe-harbor knock-in) |
| Which chromatin regulators control ECM gene programs? | CRISPR library screening with ECM-readout assays |
How to Study the negative regulation of extracellular matrix disassembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome including ECM and protease genes | Identify regulators of ECM gene programs |
| ATAC-seq | Chromatin accessibility at ECM-responsive elements | Map regulatory elements controlling matrix-remodeling genes |
| Gelatin degradation assay | Protease-mediated matrix breakdown | Functional readout of ECM disassembly |
| Zymography | Activity of secreted matrix-degrading proteases | Quantify protease output after perturbation |
| Live-cell adhesion imaging | Focal adhesion and podosome dynamics | Measure disassembly of degradation machinery |
| Proteomics of matrix | ECM composition and cross-linking | Assess matrix preservation versus degradation |
| Phospho-signaling assays | Calcium, ERK, and p38 MAPK activity | Test signaling requirement for podosome disassembly |
| CRISPR library screening | Gene requirement for ECM preservation | Discover novel negative regulators of ECM disassembly |
Transcriptomic and chromatin profiling
RNA sequencing and chromatin accessibility assays such as ATAC-seq can define how candidate regulators alter ECM-related transcriptional programs. Chromatin accessibility dynamics have been mapped in infected epithelial cells, revealing infection-linked remodeling of ECM programs. ECM-regulated gene expression requires cooperation of SWI/SNF and transcription factors, so chromatin profiling is essential to identify the regulatory elements that control matrix-remodeling genes. Endothelial chromatin-remodeling enzymes regulate production of critical ECM components, and their loss can be scored by transcriptomic changes in ECM genes.
Matrix degradation and adhesion imaging
Live-cell and fixed-cell imaging of focal adhesions and podosomes quantifies the structures that execute ECM degradation. FAK controls motile and invasive phenotypes, and imaging of adhesion turnover reports on this axis. Adhesion-derived condensates control availability of adhesion components, so condensate imaging complements adhesion dynamics measurements. Osteoprotegerin-induced podosome disassembly can be visualized directly by fluorescence microscopy of actin-rich adhesion structures.
Protease activity and matrix composition assays
Gelatin or collagen degradation assays, zymography, and matrix composition proteomics measure the net output of ECM disassembly. Because ECM disassembly results in breakdown of the extracellular matrix, these assays provide a functional readout of GO:0010716. Matrix density itself modulates cell phenotype, so controlled matrix coatings are important for reproducible measurements. Receptor-driven changes in membrane architecture, such as MARCO-induced dendritic processes, can be combined with matrix assays to link receptor state to degradation.
Signaling pathway perturbation
Pharmacological and genetic perturbation of calcium, ERK, and p38 MAPK pathways can test their requirement for negative regulation of ECM disassembly. Osteoprotegerin induces podosome disassembly through these pathways, providing a validated perturbation paradigm. FAK pathway inhibitors can be used to test whether invasive phenotypes are reversed. Combining pathway perturbation with CRISPR knockouts of candidate regulators enables causal inference.
How CRISPR Can Be Used to Study GO:0010716 negative regulation of extracellular matrix disassembly
Knockout
CRISPR knockout of candidate genes such as PTK2 (FAK) or chromatin-remodeling subunits tests whether they are required for negative regulation of ECM disassembly. Loss of SWI/SNF components impairs ECM-regulated gene expression, so knockout models can reveal transcriptional dependence. Knockout of endothelial chromatin-remodeling enzymes reduces production of critical ECM components, providing a matrix-side readout. Knockout of TNFRSF11B signaling components would be expected to alter podosome disassembly in osteoclasts.
Point Mutation
CRISPR point mutation enables precise testing of phosphorylation sites and catalytic residues. Because osteoprotegerin induces podosome disassembly through calcium, ERK, and p38 MAPK signaling, point mutations in pathway components can dissect which residues are required. Point mutations in chromatin-remodeling ATPase domains can separate DNA translocation activity from ECM gene regulation. Such models avoid confounding effects of complete protein loss.
Knock-in
CRISPR knock-in of disease-associated variants or reporter cassettes allows allele-specific interrogation of negative regulation of ECM disassembly. Knock-in of fluorescent tags at endogenous loci enables tracking of adhesion components and condensate proteins in live cells. Knock-in of variant alleles in ECM genes can test whether matrix composition changes alter disassembly rates. Knock-in strategies are also useful for placing inducible degrons on candidate regulators.
Overexpression
CRISPR overexpression via safe-harbor knock-in tests sufficiency of a candidate regulator to suppress ECM disassembly. Overexpression of matrix components or cross-linking enzymes can increase matrix preservation and reduce effective degradation. Overexpression of MARCO induces dendritic plasma membrane processes, showing that receptor dosage can reshape adhesion architecture. Overexpression models complement knockout data to establish bidirectional causality.
How EDITGENE Supports negative regulation of extracellular matrix disassembly Research
Researchers studying negative regulation of extracellular matrix disassembly-related genes often need to determine whether a candidate gene is causally involved in restraining matrix breakdown, or whether it merely correlates with a matrix-preserving phenotype. Establishing causality requires precise genetic perturbation in relevant cell types, followed by functional assays of protease activity, adhesion dynamics, and matrix composition. EDITGENE provides end-to-end CRISPR cell model generation and screening services tailored to these questions.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of extracellular matrix disassembly research.
Frequently Asked Questions About negative regulation of extracellular matrix disassembly
What is GO:0010716 negative regulation of extracellular matrix disassembly?
GO:0010716 is a biological process term describing any process that decreases the rate, frequency or extent of extracellular matrix disassembly, the breakdown of the extracellular matrix.
What genes are involved in negative regulation of extracellular matrix disassembly?
Genes implicated include PTK2 (FAK), SWI/SNF subunits such as SMARCA4 and SMARCB1, TNFRSF11B (osteoprotegerin), MARCO, and chromatin-remodeling enzymes that control ECM gene expression.
How is extracellular matrix disassembly negatively regulated at the transcriptional level?
ECM-regulated gene expression requires cooperation of SWI/SNF chromatin-remodeling complexes and transcription factors, so chromatin accessibility at ECM-responsive promoters controls expression of matrix-remodeling genes.
What role do podosomes play in negative regulation of ECM disassembly?
Podosomes are actin-rich adhesion structures that degrade matrix; their disassembly, for example induced by osteoprotegerin through calcium, ERK, and p38 MAPK, restrains matrix breakdown.
How does focal adhesion kinase relate to ECM disassembly?
FAK controls motile and invasive cell phenotypes that depend on ECM remodeling, so modulating FAK signaling can restrain invasive, matrix-degrading behavior.
Can CRISPR be used to study negative regulation of extracellular matrix disassembly?
Yes. CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators in matrix-degrading cell types.
Which diseases involve defective negative regulation of ECM disassembly?
Cancer invasion and metastasis, inflammatory bone loss, developmental pulmonary ECM defects, and fibrosis have been linked to altered ECM disassembly control.
What assays measure negative regulation of ECM disassembly?
Gelatin degradation assays, zymography, matrix proteomics, and live-cell imaging of focal adhesions and podosomes are commonly used functional readouts.
How does ECM density affect cell phenotype and matrix remodeling?
ECM density promotes epithelial-to-mesenchymal transition by weakening cell-cell adhesions, creating feedback that shifts cells toward matrix-degrading phenotypes.
What is the difference between ECM disassembly and negative regulation of ECM disassembly?
ECM disassembly is the breakdown of the extracellular matrix, whereas negative regulation of ECM disassembly (GO:0010716) comprises processes that decrease the rate, frequency or extent of that breakdown.
Conclusion
GO:0010716, negative regulation of extracellular matrix disassembly, captures a central control point in tissue biology: the mechanisms that restrain protease-driven breakdown of the ECM. These mechanisms operate through chromatin-level control of ECM gene expression, signaling pathways that dismantle podosomes and focal adhesions, and biophysical regulation of adhesion condensates. Because loss of this negative regulation contributes to cancer invasion, inflammatory bone disease, and fibrotic remodeling, the term is a high-value framework for both mechanistic research and therapeutic targeting. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with matrix degradation and imaging assays, provide the causal toolkit needed to move this field forward.
References
- 1. Xu R et al.. 2007. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors.. J Biol Chem 282(20):14992-9 PMID: 17387179
- 2. Hayward RJ et al.. 2020. Chromatin accessibility dynamics of Chlamydia-infected epithelial cells.. Epigenetics Chromatin 13(1):45 PMID: 33109274
- 3. Schlaepfer DD et al.. 2004. Control of motile and invasive cell phenotypes by focal adhesion kinase.. Biochim Biophys Acta 1692(2-3):77-102 PMID: 15246681
- 4. Dibus M et al.. 2026. Adhesion-derived condensates control component availability to regulate adhesion dynamics.. Nat Commun 17(1) PMID: 42248878
- 5. Kumar S et al.. 2014. Extracellular matrix density promotes EMT by weakening cell-cell adhesions.. Mol Biosyst 10(4):838-50 PMID: 24481128
- 6. Wu ML et al.. 2024. Endothelial Chromatin-Remodeling Enzymes Regulate the Production of Critical ECM Components During Murine Lung Development.. Arterioscler Thromb Vasc Biol 44(8):1784-1798 PMID: 38868942
- 7. Pikkarainen T et al.. 1999. Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes.. J Biol Chem 274(16):10975-82 PMID: 10196178
- 8. Zhao H et al.. 2015. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.. Cytokine 71(2):199-206 PMID: 25461399
